Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PF-04418948

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
PGE2 inhibits cytokine generation from human lung macrophages. However, the EP receptor that mediates this beneficial anti… Expand
2016
2016
Airway microvascular leak (MVL) involves the extravasation of proteins from post‐capillary venules into surrounding tissue. MVL… Expand
2016
2016
RATIONALE Autologous and allogeneic hematopoietic stem cell transplant (HSCT) patients are susceptible to pulmonary infections… Expand
  • table 1
Highly Cited
2015
Highly Cited
2015
BACKGROUND Inhaled prostaglandin (PG) E2 might inhibit asthmatic responses, but the mechanisms involved remain undefined… Expand
2014
2014
Airway sensory C-fibres express TRPA1 channels which have recently been identified as a key chemosensory receptor for acrolein, a… Expand
2013
2013
The guinea pig trachea (GPT) is commonly used in airway pharmacology. The aim of this study was to define the expression and… Expand
2013
2013
Prostaglandin E2 (PGE2) has been shown to inhibit IgE‐dependent histamine release from human lung mast cells. This effect of PGE2… Expand
2013
2013
Understanding the role of the EP2 receptor has been hampered by the lack of a selective antagonist. Recently, a selective EP2… Expand
2012
2012
Increases in the level of cyclooxygenase (COX)-2 and prostanoids such as prostaglandin E(2) (PGE(2)) are considered biomarkers of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2011
Highly Cited
2011
BACKGROUND AND PURPOSE Studies of the role of the prostaglandin EP2 receptor) have been limited by the availability of potent and… Expand